0000899243-15-010547.txt : 20151231 0000899243-15-010547.hdr.sgml : 20151231 20151231162932 ACCESSION NUMBER: 0000899243-15-010547 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151229 FILED AS OF DATE: 20151231 DATE AS OF CHANGE: 20151231 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NUDELMAN PHILLIP M PHD CENTRAL INDEX KEY: 0001041084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 151316111 MAIL ADDRESS: STREET 1: C/O SPACELABS MEDICAL INC STREET 2: 15220 NE 40TH ST CITY: REDMOND STATE: WA ZIP: 98053 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-12-29 0 0000891293 CTI BIOPHARMA CORP CTIC 0001041084 NUDELMAN PHILLIP M PHD 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 1 0 0 0 Stock Option (right to buy) 1.27 2015-12-29 4 A 0 100000 0.00 A 2025-12-28 Common Stock 100000 100000 D This stock option was granted on December 29, 2015 and vests on the date that is six months after the date of grant or, if earlier, the first annual meeting of CTIC's shareholders in 2016 at which one or more members of the CTIC Board of Directors are to be elected. /s/ Louis A. Bianco, as attorney-in-fact 2015-12-31